Aktiesnakken — Oktober 2010
-
Analytikere: Vestas står stærkt
http://epn.dk/brancher/energi/alternativ/article2224249.ece -
Genmab offentliggør igangsættelsen af et fase III head-to-head studie med ofatumumab til behandling af follikulært lymfom
-
good morning...
-
gang i genmab!
-
nu skal vi have gang i vestas om lidt...
-
et stort forsøg på 516 patienter....
-
Blandede bolscher fra Asien, men US op.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind